Overview
- ProKidney shares jumped 515% after revealing positive Phase 2 REGEN-007 trial results for chronic kidney disease and diabetes.
- SoundHound AI rallied nearly 12% despite a year-to-date drop of over 35%, as investors responded to renewed confidence following Nvidia’s exit.
- QuantumScape posted a 16.7% gain in a delayed reaction to a late June production update on next-generation solid-state EV batteries.
- Intel climbed 7.2% after Citigroup raised its price target and investors cheered the company’s global restructuring plans.
- Traders awaited Federal Reserve minutes as Nvidia rose 1.1%, briefly topping a $4 trillion market cap on news of a deepened OpenAI partnership.